Forte Biosciences Inc
web2Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United St...
Stage
Undisclosed
Funding
Undisclosed
Team
0
0.0Mission ScoreFixed 0-100 scale
About
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Expert Insight
Forte Biosciences Inc profile.
Expert Coverage
No published expert evaluations are available for this project yet.
Biotechnology & Medical ResearchHealthcare
0team
0evaluations
0subscribers